HuGE Literature Finder
Records
1
-
30
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| [Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
| Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study. Thrombosis research 2019 Dec 186 36-41. Dou Feifei, Zhang Yuan, Yi Jiawen, Zhu Min, Zhang Shu, Zhang Di, Zhang Yuh |
| Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology. Diagnostic cytopathology 2019 Feb . Tanaka Ryota, Sakamoto Norihiko, Suzuki Hitomi, Tachibana Keisei, Ohtsuka Kouki, Kishimoto Koji, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
| Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma. Journal of Cancer 2019 10 (1): 61-71. Li Pupu, Gao Qiongqiong, Jiang Xiangli, Zhan Zhongli, Yan Qingna, Li Zhaona, Huang Ch |
| Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics. Human pathology 2018 Sep . Shaukat Irfan, Kern Jason J, Höti Naseruddin, Zhang H, Li Jason, Zheng Gang, Askin Frederic, Gabrielson Edward, Li Qing K |
| Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study. Virchows Archiv : an international journal of pathology 2018 Apr 472 (4): 581-588. Schwegler Christine, Kaufmann Dinu, Pfeiffer David, Aebi Stefan, Diebold Joachim, Gautschi Oliv |
| Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma. Journal of thoracic disease 2018 Jan 10 (1): 398-407. Zhao Mengnan, Zhan Cheng, Li Ming, Yang Xiaodong, Yang Xinyu, Zhang Yong, Lin Miao, Xia Yifeng, Feng Mingxiang, Wang Q |
| MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy. Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
| Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma. Internal medicine journal 2018 01 48 (1): 37-44. Tan Lavinia, Alexander Marliese, Officer Ann, MacManus Michael, Mileshkin Linda, Jennens Ross, Herath Dishan, de Boer Richard, Fox Stephen B, Ball David, Solomon Benjam |
| Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer 2017 Feb . Tanaka Kosuke, Hida Toyoaki, Oya Yuko, Yoshida Tatsuya, Shimizu Junichi, Mizuno Tetsuya, Kuroda Hiroaki, Sakakura Noriaki, Yoshimura Kenichi, Horio Yoshitsugu, Sakao Yukinori, Yatabe Yasus |
| [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20. Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis |
| The expression of SALL4 is significantly associated with EGFR, but not KRAS or EML4-ALK mutations in lung cancer. Journal of thoracic disease 2016 Oct 8 (10): 2682-2688. Jia Xiangbo, Qian Rulin, Zhang Binbin, Zhao So |
| Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
| EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer. Oncology letters 2016 Apr 11 (4): 2371-2378. Dong Y U, Ren Weihong, Qi Jun, Jin B O, Li Ying, Tao Huiqing, Xu Ren, Li Yanqing, Zhang Qinxian, Han Baoh |
| Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar . Pietanza Catherine M, Hellmann Matthew D, Fiore John J, Smith-Marrone Stephanie, Basch Ethan M, Schwartz Lawrence H, Ginsberg Michelle S, Shouery Marwan, Newman Samantha K, Shaw Mary, Rogak Lauren J, Lash Alex, Hilden Patrick, Kris Mark |
| Genetic alterations in lung adenocarcinoma with a micropapillary component. Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
| Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma. European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
| KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jan . Hwang David H, Sholl Lynette M, Rojas-Rudilla Vanesa, Hall Dimity L, Shivdasani Priyanka, Garcia Elizabeth P, MacConaill Laura E, Vivero Marina, Hornick Jason L, Kuo Frank C, Lindeman Neal I, Dong F |
| microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proceedings of the National Academy of Sciences of the United States of America 2015 Dec 112 (48): 14924-9. Gasparini Pierluigi, Cascione Luciano, Landi Lorenza, Carasi Stefania, Lovat Francesca, Tibaldi Carmelo, Alì Greta, D'Incecco Armida, Minuti Gabriele, Chella Antonio, Fontanini Gabriella, Fassan Matteo, Cappuzzo Federico, Croce Carlo |
| Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical lung cancer 2015 Dec . Ulivi Paola, Chiadini Elisa, Dazzi Claudio, Dubini Alessandra, Costantini Matteo, Medri Laura, Puccetti Maurizio, Capelli Laura, Calistri Daniele, Verlicchi Alberto, Gamboni Alessandro, Papi Maximilian, Mariotti Marita, De Luigi Nicoletta, Scarpi Emanuela, Bravaccini Sara, Turolla Gian Michele, Amadori Dino, Crinò Lucio, Delmonte Ange |
| EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect. Clinical lung cancer 2015 Aug . Sahnane Nora, Frattini Milo, Bernasconi Barbara, Zappa Francesco, Schiavone Giovanna, Wannesson Luciano, Antonelli Paola, Balzarini Piera, Sessa Fausto, Mazzucchelli Luca, Tibiletti Maria Grazia, Martin Vittor |
| Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation? Neuro-oncology 2015 Jul 17 (7): 1022-8. Wang Tony J C, Saad Shumaila, Qureshi Yasir H, Jani Ashish, Nanda Tavish, Yaeh Andrew M, Rozenblat Tzlil, Sisti Michael B, Bruce Jeffrey N, McKhann Guy M, Lesser Jeraldine, Halmos Balazs, Stoopler Mark B, Lassman Andrew B, Cheng Simon K, Isaacson Steven |
| Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer 2015 Feb 121 (3): 448-56. Villaruz Liza C, Socinski Mark A, Abberbock Shira, Berry Lynne D, Johnson Bruce E, Kwiatkowski David J, Iafrate A John, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross, Sequist Lecia V, Haura Eric B, Ladanyi Mark, Kurland Brenda F, Kugler Kelly, Minna John D, Bunn Paul A, Kris Mark |
| Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations. PloS one 2015 10 (11): e0142306. Lim Jeong Uk, Yeo Chang Dong, Rhee Chin Kook, Kim Yong Hyun, Park Chan Kwon, Kim Ju Sang, Kim Jin Woo, Lee Sang Haak, Kim Seung Joon, Yoon Hyoung Kyu, Kim Tae-Jung, Lee Kyo You |
| Molecular alterations in non-small cell lung carcinomas of the young. Human pathology 2014 Dec 45 (12): 2379-87. VandenBussche Christopher J, Illei Peter B, Lin Ming-Tseh, Ettinger David S, Maleki Zah |
| Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2014 Mar 83 (3): 389-95. Kim Min Hwan, Shim Hyo Sup, Kang Dae Ryong, Jung Ji Ye, Lee Chang Young, Kim Dae Joon, Lee Jin Gu, Bae Mi Kyung, Kim Hye Ryun, Lim Sun Min, Kim Eun Young, Park Ji Soo, Chung Kyung Young, Kim Hyun-Jung, Kim Joo Hang, Cho Byoung Ch |
| Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients. OncoTargets and therapy 2014 7 513-24. Li Hang, Hu Haichuan, Wang Rui, Pan Yunjian, Wang Lei, Li Yuan, Zhang Yang, Ye Ting, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu |
| Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma. Cancer cytopathology 2013 Mar . Cai G, Wong R, Chhieng D, Levy GH, Gettinger SN, Herbst RS, Puchalski JT, Homer RJ, Hui P |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: